{"id":"W1972705109","doi":"10.1016/s1078-1439(02)00182-5","title":"Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer","year":2002,"lang":"en","type":"article","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Gemcitabine; Cisplatin; Oncology; Term (time); Cancer; Medicine; Internal medicine; Chemotherapy; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00463099,0.000980012,0.002902912,0.0005633149,0.0009658507,0.001393355,0.000771759,0.001533283,0.002192503],"category_scores_gemma":[0.002754503,0.0005121063,0.002660324,0.0008024716,0.00113167,0.001706156,0.0007286443,0.004413039,0.0004761356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001337695,"about_ca_system_score_gemma":0.001592386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000880391,"about_ca_topic_score_gemma":0.002755893,"domain_scores_codex":[0.9985498,0.0008277793,0.0001025464,0.0001697397,0.00008780944,0.0002623569],"domain_scores_gemma":[0.998225,0.0004716751,0.0002950028,0.0001866113,0.00009415531,0.0007275231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8562701,0.01398796,0.008901201,0.0009109789,0.00288429,0.0001387579,0.0003606252,0.003309306,0.007266542,0.0002078512,0.002674993,0.1030874],"study_design_scores_gemma":[0.3675427,0.5814795,0.03857449,0.000161269,0.002977513,0.0002832843,0.0001701735,0.001362191,0.002910342,0.0004978901,0.00397852,0.00006219705],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9861427,0.01019828,0.0004056954,0.000663628,0.0003048293,0.0005136048,0.0006280974,0.00003972993,0.001103369],"genre_scores_gemma":[0.9916732,0.00368696,0.0004228532,0.0005801,0.000188717,0.0008415253,0.001178892,0.00002350233,0.001404249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00463099,"threshold_uncertainty_score":0.02449137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08471538991158399,"score_gpt":0.3853444164681769,"score_spread":0.3006290265565929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}